Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study suggests HPV16 can skirt the immune system

16.07.2003


Human papillomavirus 16 (HPV16), the virus responsible for approximately half of all cervical cancers, appears to be better at dodging the immune system than other HPV types, according to a large study of HIV-positive women in the July 16 issue of the Journal of the National Cancer Institute. The findings may help explain why HPV16 plays such a major role in causing cervical cancer in the general population.

Whereas other HPV types have a lower prevalence and incidence among women with stronger immune systems (in theory, the stronger the immune system, the better it is at fighting off infections), researchers detected similar levels of HPV16 in women with both weak and strong immune systems.

More than 30 types of HPV are known to infect the genital epithelium. HPV16 has been the strain most strongly associated with cervical cancer and its precursor lesions. What sets HPV16 apart from other HPV types has not been clear. A preliminary analysis of a study on HPV infection among women positive for HIV, the virus that causes AIDS, suggested that HPV16 may be less associated with immune status than other HPV types.



To confirm this theory, Howard D. Strickler, M.D., and Robert D. Burk, M.D., of the Albert Einstein College of Medicine in Bronx, N.Y., and their colleagues compared the prevalence and incidence of different HPV types among HIV-positive women with varying levels of T cells, an indicator of immune status.

The final analysis included 2,058 HIV-positive women from the Women’s Interagency Human Immunodeficiency Virus Study and 871 HIV-positive women from a separate HIV Epidemiology Research Study. The women were examined during repeat study visits where cervical tissue samples were collected and HPV-type analysis was performed.

The researchers found that the prevalence ratio for HPV16, calculated by comparing prevalence rates of each HPV type for women with low versus high T-cell count, was low compared with that of other HPV types at every visit in both cohorts, suggesting that HPV16 is less influenced by the immune system than other HPV types.

In fact, the summary prevalence ratio for HPV16 was statistically significantly lower than that of all other HPV types combined. The incidence of HPV16 was also less associated with T-cell count than the incidence of other HPV types.

"The predominance of HPV16 in cervical disease in the general population might be explained partly by its ability to avoid immune clearance and the effects that this avoidance might have on the frequency and duration of infection," the authors write.

They say that the results of this study raise a number of testable hypotheses. "If it is true that the major etiologic risk factor for cervical cancer, HPV16, is not strongly affected by immune status, this fact could also help explain why cervical cancer rates appear to be only moderately increased in HIV/AIDS-affected women compared with HIV-seronegative women," they write.

Similarly, the use of highly active antiretroviral therapy (HAART) to improve immune status might only have a moderate effect on lowering an HIV-positive woman’s risk of developing precancerous lesions and cervical cancer. "We predict that the use of HAART in HIV-seropositive women will reduce the incidence, duration, and progression of cervical lesions, but that its effect will be less on lesions related to HPV16 than on those related to other HPV types," the authors say.

They add that additional studies should be able to address these predictions.

Contact:
Karen Gardner
Albert Einstein College of Medicine
Fon 001 - 718-430-3101
Email: kgardner@aecom.yu.edu

Linda Wang | EurekAlert!

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>